Abstract:

Objective To investigate the clinical efficacy and safety of laparoscopic total mesorectal excision (LME) for rectal cancer. Method From August 2020 to March 2022, 69 rectal cancer patients in Shuyang Hospital Affiliated to Xuzhou Medical University were selected and analyzed. The control group (blue ball, 34 cases) and the observation group (red ball, 35 cases) were randomly divided by red blue ball. The control group was treated by open total mesorectal excision, and the observation group was treated by laparoscopic total mesorectal excision, Record and compare the difference of operation indexes and recovery time of patients in each group, and observe and count the probability of postoperative complications of patients in the two groups. Result The total operation time (181.23 ± 15.21) min in the observation group was longer than that in the control group (t=15.285, P ＜ 0.05),

and the number of lymph node dissection (14.02 ± 4.02) had no significant difference compared with the control group (t=0.113, P ＞ 0.05). In addition, the total probability of postoperative complications in the observation group was 2.86% lower than that in the control group (χ2= 4.803，P ＜ 0.05）. Conclusion Laparoscopic total mesorectal excision is the first choice for clinical treatment of rectal cancer, which has the advantages of less damage to patients, rapid recovery, fewer complications and ideal safety.

Key words: Laparoscopic total mesorectal excision, Rectal cancer, Surgical indicators, Complication